• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Organogenesis Holdings Inc. - Class A (NQ:ORGO)

    1.765 +0.045 (+2.62%)
    Streaming Delayed Price Updated: 12:38 PM EDT, Aug 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 284,928
    Open 1.730
    Bid (Size) 1.760 (3,400)
    Ask (Size) 1.770 (3,600)
    Prev. Close 1.720
    Today's Range 1.730 - 1.790
    52wk Range 1.540 - 7.077
    Shares Outstanding 131,261,833
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Organogenesis (ORGO) Q2 2026 Earnings Call Transcript ↗
    CMS policy changes drove 58% revenue decline, but sequential recovery signals stabilization. 
    Via The Motley Fool
    Topics Earnings
    What's going on in today's session ↗
    Via Chartmill

    Performance

    YTD
    -61.9%
    -61.9%
    1 Month
    -32.9%
    -32.9%
    3 Month
    -28.8%
    -28.8%
    6 Month
    -52.8%
    -52.8%
    1 Year
    -61.5%
    -61.5%

    More News

    Read More
    Which stocks are gapping on Friday? ↗
    Via Chartmill
    Top movers in Friday's pre-market session ↗
    Via Chartmill
    Organogenesis Holdings (NASDAQ:ORGO) Plunges 17% as Q2 Revenue and EPS Miss Estimates ↗
    Via Chartmill
    Organogenesis Holdings Inc (NASDAQ:ORGO) Soars on Stellar Q4 Earnings Beat ↗
    Via Chartmill
    News headline image
    Organogenesis Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
    From Biotech Insider
    Via GlobeNewswire
    News headline image
    The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
    From World Street Intelligence
    Via GlobeNewswire
    News headline image
    Organogenesis (ORGO) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Organogenesis Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens
    Via MarketMinute
    News headline image
    Organogenesis (ORGO) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Get insights into the top gainers and losers of Monday's after-hours session. ↗
    Via Chartmill
    News headline image
    Unusual volume stocks in Monday's session ↗
    Via Chartmill
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    Keep an eye on the top gainers and losers in Friday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    These stocks are gapping in today's session ↗
    Via Chartmill

    Frequently Asked Questions

    Is Organogenesis Holdings Inc. - Class A publicly traded?
    Yes, Organogenesis Holdings Inc. - Class A is publicly traded.
    What exchange does Organogenesis Holdings Inc. - Class A trade on?
    Organogenesis Holdings Inc. - Class A trades on the Nasdaq Stock Market
    What is the ticker symbol for Organogenesis Holdings Inc. - Class A?
    The ticker symbol for Organogenesis Holdings Inc. - Class A is ORGO on the Nasdaq Stock Market
    What is the current price of Organogenesis Holdings Inc. - Class A?
    The current price of Organogenesis Holdings Inc. - Class A is 1.765
    When was Organogenesis Holdings Inc. - Class A last traded?
    The last trade of Organogenesis Holdings Inc. - Class A was at 08/18/26 12:38 PM ET
    What is the market capitalization of Organogenesis Holdings Inc. - Class A?
    The market capitalization of Organogenesis Holdings Inc. - Class A is 231.68M
    How many shares of Organogenesis Holdings Inc. - Class A are outstanding?
    Organogenesis Holdings Inc. - Class A has 232M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.